Drug company executive was vilified for dramatically boosting drug prices
By CBC News
Pharmaceutical entrepreneur Martin Shkreli, vilified for buying up drug companies and then dramatically boosting the prices of some medications, has been charged by the FBI with securities fraud related to his former hedge fund and a drug company he once ran.
Shkreli, 32, currently the CEO of Turing Pharmaceuticals, was taken into custody at his New York City home Thursday.
Read more » CBC
See more » http://www.cbc.ca/news/business/martin-shkreli-arrest-fbi-1.3369271